Homepage | European Medicines Agency
WebFifth European Medicines Agency (EMA) and the Association of the European Self-Medication Industry (AESGP) bilateral meeting. Online. European Medicines Agency, Amsterdam, the Netherlands. Start date: 29 April 2024, 10:00 (CEST)
Medicines | European Medicines Agency
WebEMA's role. The European Medicines Agency (EMA) facilitates development and access to medicines for countries within the European Union (EU). EMA evaluates applications for marketing authorisation submitted via the centralised procedure, monitors the safety of medicines across their lifecycle and provides information to healthcare professionals ...
About us | European Medicines Agency
WebThe European Medicines Agency (EMA) is a decentralised agency of the European Union (EU). It is responsible for the scientific evaluation, supervision and safety monitoring of medicines. EMA Working for every patient in Europe (video in English, with subtitles in 24 different languages) ~ 2 mins. EMA protects public and animal health in EU ...
European Medicines Agency - Wikipedia
WebThe European Medicines Agency (EMA) operates as a decentralised scientific agency (as opposed to a regulatory authority) of the European Union (EU) and its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use. [8]
European Medicines Agency – EMA | European Union
WebCompanies apply to it for a single marketing authorisation, which is issued by the European Commission. If granted, this enables them to market the medicine concerned throughout the EU and the EEA. Given the wide-ranging scope of the centralised procedure, most genuinely innovative medicines marketed in Europe are authorised by the EMA.
Home - Clinical Data Publication - clinicaldata.ema.europa.eu
WebThe clinical data for COVID-19 vaccine Vaxzevria support a safety and efficacy update on adverse drug reactions frequency. This is based on final analysis from studies including COV001, COV002, COV003 and COV005. More information on Vaxzevria is available on EMA's corporate website. 17/04/2024: Clinical data published.
Skip to content